Tracking UNCY? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Unicycive Therapeutics, Inc. (UNCY) short interest & options flow

NASDAQ

Unicycive Therapeutics heads into the week after a Q1 earnings miss with analysts trimming targets but the stock, paradoxically, holding its ground. The most important development on UNCY right now is the widening gap between analyst caution and the stock's resilience. The company reported Q1 EPS of -$0.54 on May 12, missing the -$0.46 consensus estimate by $0.08. The…

$3.78+3.28% 1d+0.80% 1w-8.03% 1mClose: 11 Nov 2026

Short interest % of float: High; Live SI on ORTEX →
Cost to borrow: Dropping; Live CTB on ORTEX →
Availability: Low; Live availability on ORTEX →

Market cap: $105M
Next earnings: 12 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Unicycive Therapeutics, Inc. (UNCY) share price and short interest (% of free float), six months to November 11, 2026

UNCY news and analysis

RSS

No long-form analysis yet for UNCY. Pulse alerts and the live data picture are available on ORTEX.

Open UNCY on ORTEX →

Want the live picture for UNCY?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for UNCY — free to start on ORTEX.

We value your privacy

UNCY news and analysis

Want the live picture for UNCY?